Vicarious Surgical named Stephen From as CEO, effective Aug. 7. Co-founder Adam Sachs will step down as CEO and remain on the ...

The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing ...

Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA ...

Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

More than 60 companies, including Amazon, Google, UnitedHealth and Epic, have pledged to participate in the initiative, which ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

The company predicted a full-year impact of 200 million to 250 million euros, down from its previous forecast of up to 300 ...

The company previously forecast an up to 300 million euro tariff impact in 2025 before the U.S. struck agreements with China ...

Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and ...

Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on ...

This earnings season, top medical device companies have dramatically reduced their expectations for tariff impacts in 2025.

Olympus and Revival Healthcare Capital agreed to invest up to $458 million combined to co-found a company that will develop a ...